In a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, Ruth L. Katz, M.D., professor of pathology at The University of Texas M. D. Anderson Cancer Center, and her colleagues used a fluorescence in situ hybridization method for detection of genetically abnormal cells, without resorting to antibody capture. They found that patients with non-small cell lung cancer had significantly higher levels of circulating abnormal cells than controls, and the numbers of abnormal cells increased with the stage of disease. The AACR hosted a teleconference to discuss these findings and the wider issue of circulating tumor cells in cancer research on Thursday, July 22, 2010, at 1:00 p.m. ET. Read the press release for more information and listen to a recording of the teleconference below.
Listen to a recording of the teleconference:
* the mp3 of the teleconference (6.4 MB, 27 minutes and 30 seconds)
*On a PC, right mouse click on the "Download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.